A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allen Radin, MD
Regeneron Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Santa Maria, California, United States
- Facility name not stated
Boca Raton, Florida, United States
- Facility name not stated
Clearwater, Florida, United States
- Facility name not stated
Daytona Beach, Florida, United States
- Facility name not stated
Delray Beach, Florida, United States
- Facility name not stated
Palm Harbor, Florida, United States
- Facility name not stated
Idaho Falls, Idaho, United States
- Facility name not stated
Worcester, Massachusetts, United States
- Facility name not stated
Lansing, Michigan, United States
- Facility name not stated
Flowood, Mississippi, United States
- Facility name not stated
Kalamzaoo, Missouri, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Reno, Nevada, United States
- Facility name not stated
Charlotte, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Toledo, Ohio, United States
- Facility name not stated
Oklahoma City, Oklahoma, United States
- Facility name not stated
Duncansville, Pennsylvania, United States
- Facility name not stated
Greenville, South Carolina, United States
- Facility name not stated
Orangeburg, South Carolina, United States
- Facility name not stated
Hixson, Tennessee, United States
- Facility name not stated
Austin, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2008
- Primary completion
- 31 Aug 2009
- Completion
- 31 Aug 2009
- Last update posted
- 30 Sept 2013
- Registered enrollment
- 60
- Registry id
- NCT01011959
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.